[First results of a new treatment of Parkinson's disease and of parkinsonism; therapeutic effect of 3-phenyl-3-(beta-diethylamino-ethyl)-2, 6-dioxo piperidine alone and with reserpine and ritalin; preliminary note].
D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D008774:Methylphenidate; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy*; D020734:Parkinsonian Disorders; D010880:Piperidines / Q000627:therapeutic use*; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants; D010276:Parasympatholytics; D010880:Piperidines; D046948:Secologanin Tryptamine Alkaloids; D008774:Methylphenidate; C032727:piperidine; D012110:Reserpine
ANALEPTICS/therapeutic use; PARALYSIS AGITANS/therapy; PARASYMPATHOLYTICS/therapeutic use; PIPERIDINES/therapeutic use; RAUWOLFIA ALKALOIDS/therapeutic use
Primi risultati di nuove terapie nel morno di Parkinson e parkinsonismi; attività terapeutiche del 3-fenil-3-b-dietilamino-etil-2-6-diossi-piperidin-cloridrato somministrato isolatamente ed in associazione con reserpina e ritalin; nota preventiva.